Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA.
European Plotkin Institute for Vaccinology, Université libre de Bruxelles, Brussels, Belgium.
J Clin Invest. 2024 Oct 15;134(20):e180560. doi: 10.1172/JCI180560.
BACKGROUNDMost humans have been infected with cytomegalovirus (CMV) by midlife without clinical signs of disease. However, in settings in which the immune system is undeveloped or compromised, the virus is not adequately controlled and consequently presents a major infectious cause of both congenital disease during pregnancy as well as opportunistic infection in children and adults. With clear evidence that risk to the fetus varies with gestational age at the time of primary maternal infection, further research on humoral responses to primary CMV infection during pregnancy is needed.METHODSHere, systems serology tools were applied to characterize antibody responses to CMV infection in pregnant and nonpregnant women experiencing either primary or chronic infection.RESULTSWhereas strikingly different antibody profiles were observed depending on infection status, limited differences were associated with pregnancy status. Beyond known differences in IgM responses used clinically for identification of primary infection, distinctions observed in IgA and FcγR-binding antibodies and among antigen specificities accurately predicted infection status. Machine learning was used to define the transition from primary to chronic states and predict time since infection with high accuracy. Humoral responses diverged over time in an antigen-specific manner, with IgG3 responses toward tegument decreasing over time as typical of viral infections, while those directed to pentamer and glycoprotein B were lower during acute and greatest during chronic infection.CONCLUSIONIn sum, this work provides insights into the antibody response associated with CMV infection status in the context of pregnancy, revealing aspects of humoral immunity that have the potential to improve CMV diagnostics.FUNDINGCYMAF consortium and NIH NIAID.
大多数人在中年时就已经感染了巨细胞病毒(CMV),但没有出现疾病的临床症状。然而,在免疫系统发育不全或受损的情况下,病毒无法得到有效控制,因此成为妊娠期间先天性疾病以及儿童和成人机会性感染的主要病原体。鉴于母体初次感染时的胎龄与胎儿患病风险密切相关,因此需要进一步研究妊娠期间初次 CMV 感染的体液免疫反应。
本研究采用系统血清学工具,对经历初次或慢性感染的孕妇和非孕妇的 CMV 感染的抗体反应进行了特征描述。
根据感染状态,观察到的抗体谱截然不同,但与妊娠状态相关的差异有限。除了临床上用于识别初次感染的 IgM 反应的差异外,观察到的 IgA 和 FcγR 结合抗体以及抗原特异性之间的差异可以准确预测感染状态。机器学习被用于准确地定义从初次感染到慢性感染的转变,并预测感染时间。抗体反应以抗原特异性的方式随时间发生变化,随着时间的推移,针对包膜的 IgG3 反应逐渐减少,这是典型的病毒感染特征,而在急性感染期间和慢性感染期间,针对五聚体和糖蛋白 B 的 IgG3 反应较低。
综上所述,本研究在妊娠背景下提供了与 CMV 感染状态相关的抗体反应的见解,揭示了体液免疫的各个方面,这些方面有可能改善 CMV 的诊断。
CymaF 联盟和美国国立卫生研究院国家过敏和传染病研究所。